Inactive

Sources Sought Notice This notice is for planning purposes only and shall not be considered an invitation for bid, request for quotation, request for proposal, or as an obligation of the government to... Sources Sought Notice This notice is for planning purposes only and shall not be considered an invitation for bid, request for quotation, request for proposal, or as an obligation of the government to acquire any products or services. Responses to this notice will be used for informational purposes only. No entitlement to payment of direct or indirect costs from the government will arise as a result from a response to this announcement. No contract will be awarded from this notice. The information requested in this notice will be used to determine if there are sufficient socioeconomic small business concerns that are capable of performing the work described for the requirement. The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office (NCO) 17 is seeking sources for the following procurement: Laboratory Testing Services; Contractor shall provide Reference Laboratory Testing Services to the VA, Central Texas Veterans Health Care System (CTVHCS), in accordance with the attached Performance Work Statement. BACKGROUND Olin Teague VA Medical Center Doris Miller VA Medical Center Austin Outpatient 1901 Veterans Memorial Dr. 4800 Memorial Dr. 7901 Metropolis Dr. Temple, TX 76504-7451 Waco, TX 76711-1329 Austin, TX 78744 DESCRIPTION OF SERVICES The CTVHCS requires reference laboratory testing of patient specimens that the facilities do not have the capacity or capability to perform on-site. A laboratory test is an examination, diagnostic, or monitoring procedure on a human specimen removed from the body to determine specific information for diagnosis, treatment, or prevention of disease, and to detect the impairment of health status, or to assess the health of human beings. Laboratory testing must be provided in compliance with the requirements in VHA Handbook 1106.01 and 42 CFR Part 493. The contractor must hold and maintain a certificate of accreditation from the Centers for Medicare & Medicaid Services (CMS), as meeting the requirements of the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and must hold and maintain accreditation by the College of American Pathologists (CAP) to perform the services. See attached Performance Work Statement for the performance requirements. RESPONSE If interested, please provide the following information in a response: 1. Name of Company 2. Point of Contact; name, phone number and email address 3. DUNS number 4. Company socio-economic status (i.e., Small Business) 5. Capability Statement 6. Vendors expressing interest in participating in the requirement must complete and provide the attachment; Exhibit A, Estimated Base Period Quantities, with the response. a. In column F, make an entry for each test description, as yes or no for whether vendor will self-perform the specific test in-house. b. In column G, make an entry for each test description, with the name of the laboratory performing the test. Provide a copy of the CLIA certificate of accreditation for each laboratory listed in the attachment. The certificate must include the Lab Certification Code(s) and effective date for the laboratory specialties and subspecialties the laboratory is certified to perform. In addition, for each laboratory listed in the attachment (Exhibit A), provide a declaration signed by the Laboratory Director listed on the CLIA Certificate of Accreditation that identifies which laboratory tests identified in the attachment are currently being performed at that laboratory. c. In column H, make an entry for each test description, with the CLIA certificate number of the laboratory performing the test. Failure to provide the requested information for any test listed in the attachment (Exhibit A), or failure to provide the certificate of accreditation for any laboratory identified in the attachment will be considered by the VA to be a statement that the vendor responding to this notice is unable to provide that particular test. The information provided in a response to this notice may be used in developing an acquisition approach. Interested parties are responsible for adequately marking any proprietary or competitive sensitive information that is provided in a response. Interested firms must respond to the notice to be considered. For any questions regarding this notice email the solicitation point of contact no later than COB 04/30/2020. This notice is amended to respond to questions asked during the notice - see attached document titled Questions and Responses. The notice has not been extended.